Clinical evidence supporting the use of activated zeolite to detoxify heavy metals
The slow accumulation of heavy metals has been implicated in numerous neurological diseases, including Parkinson's, Alzheimer's, autism, ADHD, learning disorders, hypertension, cardiac rhythm disorders, renal disease and reproductive problems.
The following excerpts come from a study that was published in 2009 and is self-explanatory in its introduction, abstract and conclusion, supporting the use of activated zeolite as an 'alternate modality of therapy to traditional treatment through chelation' in the removal of stored heavy metals from the body.
Read the original findings by its authors below...
Introduction
In the past few years there has been a growing recognition that in contradistinction
to the rare occurrence of acute heavy metal toxicity, illness due to the chronic accumulation of metals, such as lead, mercury, arsenic, cadmium, and aluminium is far more common than ever suspected. Because the accumulation of these metals takes place over months or years, there are frequently no acute effects, and because the symptoms are usually quite non-specific, only the astute clinician suspects chronic metal poisoning.
The slow accumulation of heavy metals has been implicated in numerous neurological diseases, including autism and attention-deficit hyperactivity disorder, encephalopathy, Parkinson’s disease, and Alzheimer’s disease. Furthermore, specific links have been made between lead and mercury accumulation and the development of learning disorders other than autism spectrum disorders. In addition, cardiovascular diseases, such as hypertension and cardiac rhythm disorders, have been linked to the accumulation of lead, renal disease has been linked to exposures to lead, arsenic, cadmium, and mercury,
and reproductive problems including infertility have been linked to numerous heavy metal exposures.
Abstract: Effective treatment of chronic illness resulting from the long-term buildup of heavy metals in the body, such as chelation therapy, presents numerous clinical challenges, including undesirable side effects and unpredictable efficacy. Use of a naturally occurring zeolite, clinoptilolite, to remove these toxic substances may offer an efficacious and safe alternative to the traditional approaches. This study was designed to evaluate the ability of activated clinoptilolite suspended in water (ACS) to remove heavy metals from the body through urinary excretion without the undesirable removal of physiologically important electrolytes.
Conclusion
In this study, we have presented clinical evidence supporting the use of an activated clinoptilolite suspension to safely and effectively increase the urinary excretion of potentially toxic heavy metals in healthy volunteers without negatively impacting the electrolyte profiles of the participants.
Significant increases in the urinary excretion of aluminium, antimony, arsenic, bismuth, cadmium, lead, mercury, nickel and tin were observed in the subjects participating in the two study groups as compared to placebo controls. Since spectroscopic analysis showed no detectable contamination of the activated clinoptilolite suspension with the metals being evaluated, it is reasonable to assume that this observation was attributable to increased excretion of stored toxins and certainly led to a reduction in the overall toxic metal body burden of the participants.
The use of activated clinoptilolite suspension to remove these ubiquitous
toxins from the body presents an alternate modality of therapy to traditional treatment through chelation.
The full study can be read by clicking the following link: